Treatment of Insomnia in the Elderly
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for insomnia in elderly patients, as it has been shown to be highly effective with sustained benefits for up to 2 years. 1
Non-Pharmacological Approaches
First-Line Treatment: CBT-I
- CBT-I combines multiple behavioral treatments including:
- Sleep hygiene instruction
- Stimulus control
- Sleep restriction
- Cognitive restructuring 2
- The American College of Physicians strongly recommends starting with CBT-I for at least 4-6 weeks before considering pharmacotherapy 1
- CBT-I has demonstrated clinically meaningful improvements in sleep onset latency, wake time after sleep onset, and sleep efficiency 3
Evidence-Based Single-Component Therapies
When full CBT-I is not available, these individual components have shown efficacy:
Sleep Restriction/Sleep Compression
- Limits time in bed to match actual sleep time
- Gradually increases time in bed as sleep efficiency improves
- Has met evidence-based criteria for efficacy in older adults 2
Sleep Hygiene Education
- Addresses behaviors that interfere with sleep:
- Note: Sleep hygiene alone is usually not adequate for severe chronic insomnia but works well when combined with other modalities 2
Pharmacological Approaches
If non-pharmacological approaches are insufficient after 4-6 weeks, consider medication:
First-Line Medications
Ramelteon (8mg)
Low-dose non-benzodiazepine receptor agonists
- Zolpidem: 5mg for elderly (reduced from standard 10mg adult dose)
- Effective for sleep onset insomnia
- Superior to placebo on measures of sleep latency 5
- Eszopiclone: 1-2mg for elderly
- Effective for both sleep onset and maintenance
- Superior to placebo on measures of sleep latency and wake time after sleep onset 6
- Zaleplon: 5mg for elderly
- Useful for sleep onset difficulties 1
- Zolpidem: 5mg for elderly (reduced from standard 10mg adult dose)
Low-dose Doxepin (3-6mg)
- Effective for sleep maintenance insomnia 1
Suvorexant
- Consider for sleep maintenance insomnia
- Moderate-quality evidence showing improved treatment response 1
Medications to Avoid in the Elderly
- Benzodiazepines (temazepam, triazolam)
- High risk of falls, cognitive impairment, and dependence 1
- Antihistamines (diphenhydramine)
- Strong anticholinergic effects
- Risk of confusion and urinary retention 1
- Multiple sedating medications
- Increased fall risk, especially in older adults 1
Treatment Algorithm
Initial Assessment
- Use standardized tools (Insomnia Severity Index or Pittsburgh Sleep Quality Index)
- Identify specific insomnia type (onset vs. maintenance)
- Document sleep patterns with a 2-week sleep diary 1
First-Line Treatment (4-6 weeks)
- Implement CBT-I when available
- If full CBT-I is not accessible, use single-component therapies (stimulus control, sleep restriction, or relaxation therapy)
- Implement sleep hygiene practices
If Non-Pharmacological Treatment Insufficient
- For sleep onset insomnia: Ramelteon 8mg or low-dose zolpidem 5mg
- For sleep maintenance: Low-dose doxepin 3-6mg or suvorexant
- For both onset and maintenance: Eszopiclone 1-2mg
Monitoring and Follow-Up
- Schedule follow-up within 7-10 days of any treatment change
- Use standardized measures to track progress
- Monitor for 4-6 weeks before considering medication changes 1
Important Considerations
- Medication effects may be more pronounced in elderly patients
- Risk of falls increases with sedating medications
- Cognitive impairment is a potential side effect of many sleep medications
- Gradual tapering is necessary when discontinuing medications to prevent withdrawal symptoms 1
Non-pharmacological approaches should always be the foundation of insomnia treatment in the elderly, with pharmacotherapy reserved for cases where these approaches are insufficient or while waiting for CBT-I to take effect.